CoChat

CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells

Open access
Lin, Ping, Qin, Shugang, Pu, Qinqin, Wang, Zhihan, Wu, Qun, Gao, Pan, Schettler, Jacob, Guo, Kai, Li, Rongpeng, Li, Guoping, Huang, Canhua, Wei, Yuquan, Gao, George Fu, Jiang, Jianxin, Wu, Min · 2020 · Molecular Cell
Cited by 93

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Summary Cas13 has demonstrated unique and broad utility in RNA editing, nucleic acid detection, and disease diagnosis; however, a constantly active Cas enzyme may induce unwanted effects. Bacteriophage- or prophage regions-encoded anti-CRISPR (acr) molecules provide the potential to control targeting specificity and potency to allow for optimal RNA editing and nucleic acid detection by spatiotemporally modulating endonuclease activities. Using integrated approaches to screen acrVI candidates and evaluate their effects on Cas13 function, we discovered a series of acrVIA1–7 genes that block the activities of Cas13a. These VI-A CRISPR inhibitors substantially attenuate RNA targeting and editing by Cas13a in human cells. Strikingly, AcrVIAs also significantly muffle the single nucleic acid editing ability of the dCas13a RNA editing system. Mechanistically, AcrVIA1, 4, 5 and 6 bind LwaCas13a while AcrVIA2 and 3 can only bind LwaCas13-crRNA complex. These identified anti-CRISPR molecules may enable precise RNA-editing in Cas13-based application and studying phage-bacterium interaction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2020.03.033

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

Metadata

Authors
Lin, P., Qin, S., Pu, Q., Wang, Z., Wu, Q., Gao, P., Schettler, J., Guo, K., Li, R., Li, G., Huang, C., Wei, Y., Gao, G. F., Jiang, J., & Wu, M.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2020-06
Volume
78
Issue
5
Pages
850-861.e5
ISSN
1097-2765 (ISSN-L)
OpenAlex
W3018793124
Cited by
93
References
10
FWCI
4.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.